NT5DC3 Antibodies

AND NT5DC3 ELISA kits, NT5DC3 Proteins

Many biological assays use antibodies to detect NT5DC3, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with NT5DC3 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop NT5DC3 antibodies...

We validate the specificity of these antibodies to NT5DC3 by testing them on tissues known to express NT5DC3 positively and negatively. Browse below to find the NT5DC3 antibody that suites your experiment. We have 2 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: SEPTIN9 Next: RAB6B

NT5DC3 Infographic by Boster Bio

All NT5DC3 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

NT5DC3 (NM_016575) Human Over-expression Lysate

Human

$960
Cat # LS051559
100 µg

Anti-NT5DC3 Antibody Picoband®

Human

ELISA, Flow Cytometry, WB

$370
Cat # A15406-1
100 µg/vial

NT5DC3 Overview

Facts about 5'-nucleotidase domain-containing protein 3.

NT5DC3 3D structure. Source: alphafold

5'-nucleotidase domain-containing protein 3 (NT5DC3)

Gene Information

Human
Gene Name:	NT5DC3
Uniprot:	Q86UY8
Entrez:	51559

Family

Belongs to:

5'(3')-deoxyribonucleotidase family

Alternative Names

5'-nucleotidase domain-containing protein 3

Molecular Weight

Mass (kDA):
63.42 kDA

Genomic Context


Human

Location:	12q23.3
Sequence:	12; NC_000012.12 (103746315..103841239, complement)

Tissue Specificity

Expressed in brain, placenta, skeletal muscle, pancreas, testis, uterus, and small intestine. Reduced expression in pancreatic cancer cells.

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/NT5DC3

References

PMID: 15547748 by Yatsuoka T., et al. TU12B1-TY, a novel gene in the region at 12q22-q23.1 frequently deleted in pancreatic cancer, shows reduced expression in pancreatic cancer cells.